Pulmonary Complications of Novel Antineoplastic Agents for Solid Tumors
Top Cited Papers
- 1 February 2008
- Vol. 133 (2), 528-538
- https://doi.org/10.1378/chest.07-0851
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – Study of the EORTC Soft Tissue and Bone Sarcoma GroupEuropean Journal Of Cancer, 2007
- A phase II study of temozolomide therapy for poor-risk patients aged ⩾60 years with acute myeloid leukemia: low levels of MGMT predict for responseLeukemia, 2007
- Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: A phase I studyLung Cancer, 2006
- Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimusEuropean Journal Of Cancer, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinibLung Cancer, 2004
- Thalidomide: Current Role in the Treatment of Non-Plasma Cell MalignanciesJournal of Clinical Oncology, 2004
- Severe acute interstitial pnuemonia and gefitinibLung Cancer, 2004
- Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxelLung Cancer, 2003
- KW-2149-induced pulmonary toxicity is not prevented by corticosteroidsAnti-Cancer Drugs, 1999